申请人:Lindsley Craig W.
公开号:US20100179122A1
公开(公告)日:2010-07-15
Compounds of Formula (I): are HIV reverse transcriptase inhibitors, wherein R
1
, R
2
, R
3
, R
4
and R
5
are defined herein. The compounds of Formula (I) and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
公式(I)的化合物是HIV反转录酶抑制剂,其中R1、R2、R3、R4和R5在此定义。公式(I)化合物及其药学上可接受的盐在抑制HIV反转录酶、预防和治疗HIV感染以及预防、延迟发病和治疗艾滋病方面有用。这些化合物及其盐可作为药物组合物的成分,可选择与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。